Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.

Saved in:
Bibliographic Details
Title: Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.
Authors: Arranz-Nicolás J; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain. jarranz@cnb.csic.es., Martin-Salgado M; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Adán-Barrientos I; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Liébana R; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Del Carmen Moreno-Ortíz M; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Leitner J; Center for Pathophysiology, Institute of Immunology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria., Steinberger P; Center for Pathophysiology, Institute of Immunology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria., Ávila-Flores A; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Merida I; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain. imerida@cnb.csic.es.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Nov; Vol. 70 (11), pp. 3277-3289. Date of Electronic Publication: 2021 Apr 10.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33837851
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Arranz-Nicolás+J%22">Arranz-Nicolás J</searchLink>; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain. jarranz@cnb.csic.es.<br /><searchLink fieldCode="AU" term="%22Martin-Salgado+M%22">Martin-Salgado M</searchLink>; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Adán-Barrientos+I%22">Adán-Barrientos I</searchLink>; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Liébana+R%22">Liébana R</searchLink>; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Del+Carmen+Moreno-Ortíz+M%22">Del Carmen Moreno-Ortíz M</searchLink>; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Leitner+J%22">Leitner J</searchLink>; Center for Pathophysiology, Institute of Immunology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Steinberger+P%22">Steinberger P</searchLink>; Center for Pathophysiology, Institute of Immunology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Ávila-Flores+A%22">Ávila-Flores A</searchLink>; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Merida+I%22">Merida I</searchLink>; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain. imerida@cnb.csic.es.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2021 Nov; Vol. 70 (11), pp. 3277-3289. <i>Date of Electronic Publication: </i>2021 Apr 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33837851
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00262-021-02924-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3277
    Titles:
      – TitleFull: Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Arranz-Nicolás J
      – PersonEntity:
          Name:
            NameFull: Martin-Salgado M
      – PersonEntity:
          Name:
            NameFull: Adán-Barrientos I
      – PersonEntity:
          Name:
            NameFull: Liébana R
      – PersonEntity:
          Name:
            NameFull: Del Carmen Moreno-Ortíz M
      – PersonEntity:
          Name:
            NameFull: Leitner J
      – PersonEntity:
          Name:
            NameFull: Steinberger P
      – PersonEntity:
          Name:
            NameFull: Ávila-Flores A
      – PersonEntity:
          Name:
            NameFull: Merida I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2021 Nov
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0851
          Numbering:
            – Type: volume
              Value: 70
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Cancer immunology, immunotherapy : CII
              Type: main
ResultId 1